kabutan

Menicon shares rebound for first time in three days on China approval for 'Time XL' lens

Mon Apr 20, 2026 11:15 am JST Catalyst

Menicon Co., Ltd. <7780> rebounded for the first time in three days. Investors cheered news that "Time XL," a scleral lens manufactured by Menicon's Dutch subsidiary, obtained medical device approval from China’s National Medical Products Administration (NMPA).

Scleral lenses are hard contact lenses designed to provide stable vision correction and comfort for patients with irregular corneas, such as those with keratoconus. China has a high prevalence of such conditions, yet advanced domestic treatment options have remained limited. Menicon stated it aims to improve patient quality of life by expanding the product's availability across the Chinese market.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles